Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Occup Environ Med. 2021 Sep 10;78(10):699–706. doi: 10.1136/oemed-2021-107405

Temporal Association of Prostate Cancer Incidence with World Trade Center Rescue/Recovery Work

David G Goldfarb 1,2, Rachel Zeig-Owens 1,2,3, Dana Kristjansson 4,5,6, Jiehui Li 7, Robert M Brackbill 7, Mark R Farfel 7, James E Cone 7, Janette Yung 7, Amy R Kahn 8, Baozhen Qiao 8, Maria J Schymura 8, Mayris P Webber 1,2,3, Christopher R Dasaro 9, Moshe Shapiro 9, Roberto G Lucchini 10, Andrew C Todd 9, David J Prezant 1,2,3, Paolo Boffetta 11,12, Charles B Hall 3
PMCID: PMC8458078  NIHMSID: NIHMS1721112  PMID: 34507966

Abstract

Background:

The World Trade Center (WTC) attacks on 9/11/2001 created a hazardous environment with known and suspected carcinogens. Previous studies have identified an increased risk of prostate cancer in responder cohorts compared to the general male population.

Objectives:

To estimate the length of time to prostate cancer among WTC rescue/recovery workers by determining specific time periods during which the risk was significantly elevated.

Methods:

Person-time accruals began six months after enrollment into a WTC cohort and ended at death or 12/31/2015. Cancer data were obtained through linkages with 13 state cancer registries. New York State was the comparison population. We used Poisson regression to estimate hazard ratios and 95% confidence intervals; change points in rate ratios were estimated using profile likelihood.

Results:

The analytic cohort included 54,394 male rescue/recovery workers. We observed 1,120 incident prostate cancer cases. During 2002–2006, no association with WTC exposure was detected. Beginning in 2007, a 24% increased risk (HR: 1.24, 95%CI: 1.16–1.32) was observed among WTC rescue/recovery workers when compared with New York State. Comparing those who arrived earliest at the disaster site on the morning of 9/11/2001 or any time on 9/12/2001 to those who first arrived later, we observed a positive, monotonic, dose-response association in the early (2002–2006) and late (2007–2015) periods.

Conclusions:

Risk of prostate cancer was significantly elevated beginning in 2007 in the WTC Combined Rescue/Recovery Cohort. While unique exposures at the disaster site might have contributed to the observed effect, screening practices including routine prostate specific antigen screening cannot be discounted.

Introduction

The period between potential exposure to carcinogens and the development of prostate cancer is of interest from both clinical and public health perspectives. The exact amount of time between an exposure and the development of cancer in an individual is dependent on many factors including the type and dose of exposure. While estimates vary considerably, for prostate cancer, studies have demonstrated it can take between 10 and 20 years following exposure for cancers to be diagnosed.1,2 These findings, however, are based on outdated reviews of evidence and do not account for advancements in screening.3,4 This is particularly challenging given the high sensitivity of Prostate Specific Antigen (PSA) testing, and prolonged lead time of disease which has resulted in early detection of pre-symptomatic individuals.57

Recent studies have identified an increased incidence of prostate cancer among World Trade Center (WTC)-exposed responders (rescue/recovery workers) when compared to the general male population.811 However, the length of time between exposure to the toxic environment at the disaster site beginning on 9/11/2001 (9/11) and onset of cancer remains unknown. Carcinogens known to be present in relatively high quantities at the primary WTC site included asbestos, benzene, chromium, dioxins and polychlorinated biphenyls.1214 Some have suggested that these contaminants may increase the likelihood of prostate cancer and expedite oncogenesis15,16, however, this result was not found by all.17 Building on this hypothesis, one study which compared inflammatory gene expression among WTC and non-WTC-exposed prostate cancer patients, found a higher differential expression of genes related to damage to DNA repair pathways and glycolysis among tissue samples of WTC-exposed patients.18 The study also found a Th17 inflammatory response in the prostate tissue of rats exposed to WTC dust.

The current prospective cohort study will expand on previous research revealing an increased incidence of prostate cancer among WTC-exposed workers by combining three WTC-exposed responder cohorts (the Fire Department of the City of New York [FDNY]19, the General Responder Cohort [GRC]20, and the World Trade Center Health Registry [WTCHR]21) to provide the statistical power needed to explore the length of time to prostate cancer diagnosis using piecewise exponential change point models. This methodology has been previously used in studies of respiratory diseases in WTC-exposed subjects22,23 and in other research.24 The study aim was to determine the average time interval between 9/11 exposure and observed increases in prostate cancer incidence, taking into account changes expected from aging and secular trends in New York State (NYS). The amount of time from WTC exposure to the diagnosis of prostate cancer was estimated by determining the specific time periods between 2002 and 2015 during which the risk was significantly elevated compared with the NYS rate.

Methods

Study population

The source population for this study included rescue/recovery workers (n=69,102) from three WTC-exposed responder cohorts: the Fire Department of the city of New York (FDNY),19 the General Responder Cohort (GRC)20 and the World Trade Center Health Registry (WTCHR).21 Responders included firefighters, emergency medical service (EMS) providers, police, construction and communication workers, volunteers and cleanup workers. While the WTCHR also includes persons who resided, went to school and worked (in non-rescue/recovery positions) at the WTC disaster site, this study included only rescue/recovery workers. All responders who were members of any of the three cohorts and either provided informed consent for research or were covered under a research ethics board, or Institutional Review Board (IRB)-approved waiver of consent were eligible for inclusion in analyses. Additional details regarding consolidation of the WTC Combined Rescue/Recovery Cohort and data harmonization have been described elsewhere.25 To avoid selection bias, persons who enrolled into any of the cohorts after October 1, 2012, when cancer coverage began under the James Zadroga 9/11 Health and Compensation Act,26 were excluded from all analyses. Under the provisions of this enactment, WTC Health Program (WTCHP) members have access to diagnostic procedures and treatment for numerous cancers and thus, to avoid differential self-selection into the cohort were removed. Figure 1a is a flow diagram of study participants for the WTC Combined Rescue Recovery cohort (n=54,394), enumerating the exclusionary criteria.

Figure 1: Flow of study participants.

Figure 1:

Abbreviations: FDNY=Fire Department of the city of New York; GRC=General Responder Cohort; WTCHR= World Trade Center Health Registry

Outcome assessment

Prostate cancer cases defined as ICD-O-3 site C619 with malignant behavior code 3, using the Surveillance, Epidemiology, and End Results (SEER) site recode table, were obtained by matching the WTC Combined Rescue/Recovery Cohort to data from 13 state cancer registries. These states included: Arizona, California, Connecticut, Florida, Massachusetts, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Virginia, and Washington. We have examined out-migration patterns from New York City based on US Census Bureau American Community Survey data, a summary by the New York City Independent Budget Office,27 and our records for the rescue/recovery workers, and have concluded that the 13 registries resulted in approximately 90% coverage of the population. Information on tumor characteristics such as diagnosis date and stage were also provided by state cancer registries. Cancer cases obtained from multiple states registries for the same participant were reconciled and included as one case. Cancers diagnosed within six months of enrollment into any of the responder cohorts were excluded from all analyses to ensure that prevalent cases were removed and to account for potential self-selection bias (i.e., selectively enrolling into a WTCHP cohort to receive augmented cancer coverage).

Exposure measures and demographic characteristics

Researchers from the three participating cohorts developed common exposure metrics to ensure that results from collaborative studies, such as this one, be comparable. The exposure measure for our primary external analysis was presence at the WTC site, or WTC rescue/recovery work at other sites such as the Fresh Kills Landfill in Staten Island, at any time from 9/11/2001 to 6/30/2002, the time when work on the recovery effort ended. We also used a three-level exposure variable according to self-reported first arrival at a WTC disaster site: on 9/11/2001 or being caught in the dust cloud resulting from the collapse of the towers on the morning of the attacks; or on 9/12/2001; or on any other time from 9/13/2001 until 6/30/2002. Some of the hazardous substances found to be present at the disaster site are known carcinogenic agents including, but not limited to, asbestos, sulfuric acid, benzo(a)pyrene, benzene, arsenic,13,28,29 which we have posited were most ubiquitous on 9/11/2001, and gradually dissipated thereafter. Basic demographic characteristics such as sex, birth month, birth year, race/ethnicity and smoking status were available in each cohort. Since only birth month and year were available for some study participants, the 15th of each month was used to calculate age. When both birth month and day were missing, June 15th of the birth year was used. Death dates were obtained by each cohort and duplicate patients as well as discordant dates of enrollment, diagnosis, and death were resolved by the New York State Cancer Registry to ensure accurate ascertainment and person-time contributions. Death ascertainment by cancer registries is commensurate with data from the National Death Index (NDI). In a subset of our data, we looked at employment and pension records, and observed excellent completeness of mortality matches.

NYS Comparison Population

NYS population rates were used for the comparison population for our primary external analysis and were calculated using SEER*Stat software. Data were summarized in strata of person-time and cases by race/ethnicity (non-Hispanic White, non-Hispanic Black, non-Hispanic Asian/Pacific Islander, non-Hispanic American Indian, and Hispanic), age (18–19, and 20 to 85+ in 5-year increments), and calendar year (2002 to 2015).

Statistical Analyses

The outcome for all multivariable analyses was incident prostate cancer. Both comparison rates and observed cancer counts included multiple primary cancers. That is, every identified prostate cancer was counted as a case regardless of a patient’s cancer history (other than prostate). WTC Combined Rescue/Recovery Cohort data were grouped in strata of person-time and cases in the same way as the NYS comparison population. Person-time accruals began six months after enrollment into a WTC rescue/recovery cohort. This date was chosen so that prevalent cancers which had likely developed prior to 9/11 were not misclassified as incident cases. The follow-up period ended at the earlier of date of death and 12/31/2015.

We used piecewise exponential survival models to estimate hazard ratios and associated 95% confidence intervals. These models are similar to Cox regression models, but they allow the baseline hazard to change at numerous specified time intervals rather than with every event; we used one-year time intervals. The models also allow for incidence to be estimated in the reference group. The hazard ratios also have rate ratio interpretations. These rate ratios were allowed to vary over follow-up using change points. Specifically, these change point analyses were conducted to estimate the yearly intervals for which relative incidences significantly changed from one period to the next.

We first fit a model with no change points which assumed constant incidence rates for both the WTC and NYS groups throughout the entire follow-up period. Then, we fit a series of models with one change point, allowing each model to change incidence rates at a different follow-up time, at yearly intervals, with change points varying from 2003 to 2014, resulting in a total of 12 possible models. The change points were estimated using profile likelihood and we reported estimates and 95% confidence intervals for the hazard ratios which have relative rate interpretation.24,3032 Best fitting models were concluded using likelihood ratio tests. The same process was used for models with comparing two change points to one change point. In each case the combination of change points was run in separate models and then compared by profile likelihood.

The specific model was as follows:

log(Yik)=log(Tik)+k=1k=nαkwik+j=1p+1βjxi1(τj1<tikτj)+lγlzil.

Yik is the number of incident cases of prostate cancer, modeled to follow a Poisson distribution given the covariates, Tik is the total person time at risk, each for a particular stratum i and time interval k, tik is the time since exposure, and the exposures indicated by the values of xi, a binary variable taking the value of 1 for the WTC-exposed cohort, and 0 for the comparison NYS general population, and zil's represent demographic covariates age, and race/ethnicity. The wiks are dummy variables representing the one-year time intervals. βj is the log hazard ratio, also having log-relative-rate interpretation, comparing incidence in the WTC-exposed cohort to the NYS reference population for time interval j, which is the period between change points tj1 and tj. The aks were parameters representing the baseline hazard as a function of time which has cases per person time interpretation. The equation is described in greater detail, elsewhere.23 This primary external analysis using NYS as a comparison controlled for race/ethnicity, age and calendar year.

Three secondary analyses were conducted. The first was an external analysis and also used NYS as the comparison population but employed time of arrival at the WTC site as the exposure variable. This analysis excluded participants who did not report either a specific period of time they were present at the WTC site or exposure to the dust cloud (n=3,279). Additionally, non-Hispanic American Indian (n=146) participants were removed because of low power. Person-time for the 18–19, 20–24 and 25–29 age strata were excluded due to small numbers (n=8 participants, 1 prostate cancer) which led to unstable parameter estimates. The final restricted population included 50,961 participants for this secondary external analysis (Figure 1b).

The second was an internal analysis that used the same exclusionary criteria but evaluated those who arrived at the WTC site between 9/13/2001 and 6/30/2002 as the referent category. This model controlled for smoking status at baseline (ever vs. never) as well as the additional covariates used in the primary analysis. The same model equation applied to this internal analysis as to the primary analysis, except that there were three exposure categories (first arrival at WTC site on 9/11 or caught in dust cloud; first arrived on 9/12; first arrived on 9/13/2001–6/30/2002). We also calculated adjusted baseline incidence rates stratified by exposure category. These graphs were created by including an interaction term between the exposure variable and calendar year, such that each group could vary with time. For this analysis, we applied a LOESS smoothing function for point estimates and associated 95% confidence intervals.

Third, we conducted several sensitivity analyses to address the potential for surveillance bias by restricting to late-stage prostate cancers (regional and distant tumors), only. That is, regional and distant tumors are defined as those cancers that have metastasized from beyond the primary tumor (i.e., prostate) to neighboring and distant lymph nodes or organs, respectively. Categorizations were made using SEER Summary Staging Manual 2000 coding instructions.33 For each analysis, change points were evaluated, separately.

Analyses were conducted using SAS 9.4 (SAS Institute Inc. Cary, NC) and R v3.6.0.29. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines and was approved by Institutional Review Boards at Albert Einstein College of Medicine, New York City Department of Health and Mental Hygiene, the New York State Department of Health, and all thirteen cancer registries. The Icahn School of Medicine at Mount Sinai IRB ruled the research exempt. Data that support the findings of the study may be obtained from the corresponding author (CBH) upon reasonable request after approval by the Steering Committee for “Incidence, Latency, and Survival of Cancer Following World Trade Center Exposure” (NIOSH Cooperative Agreement U01 OH011932) in accordance with the study’s official Data Sharing Plan.

Results

The 54,394 participants in the final, analytic cohort yielded 1,120 prostate cancer cases in 1,120 participants diagnosed between 3/12/2002 and 12/31/2015, with 573,512 person-years of follow-up. During the same period, and using the same inclusion criteria, 207,252 cases were diagnosed in the NYS comparison population, with 105,413,892 person-years of follow-up. Demographic characteristics for the analytic cohort are presented in Table 1. The mean age at diagnosis among prostate cancer cases was 59.6 (standard deviation, SD=7.9) and ranged from 35 to 93 years old. Compared to WTC responders without prostate cancer, WTC responders with prostate cancer were significantly more likely to be non-Hispanic White (75.1% vs. 71.7%; p<0.001) or non-Hispanic Black (17.4% vs. 8.3%; p<0.001) and were significantly less likely to be Hispanic (7.0% vs. 14.8%; p<0.001). There were significantly more ever smokers among prostate cancer cases when compared to persons without prostate cancer (46.9% vs. 38.9%; p<0.001). Among persons with and without prostate cancer, 92 (8.2% of 1,120) and 2,166 (4.1% of 53,274) had another (non-prostate) malignancy within the study period, respectively. Among persons with prostate cancer, the median (inter-quartile range, IQR) time from 9/11 to diagnosis was 9.4 years (7.3, 12.1). The majority of cases were diagnosed between 2009–2015 (n=734; 66%).

Table 1a:

Select demographic characteristics of WTC Combined Rescue and Recovery cohort

No. (%) of Responders
Prostate cancer Cases (n=1,120) Other rescue/recovery workersa (n=53,274) Total (n=54,39)
Characteristics
Age at study entry
 18–19 0 (0.00) 28 (0.05) 28 (0.05)
 20–24 ≤5 (≤1.00) 868 (1.63) 869 (1.60)
 25–29 0 (0.00) 3,227 (6.06) 3,227 (5.93)
 30–34 12 (1.07) 6,714 (12.60) 6,726 (12.37)
 35–39 32 (2.86) 10,109 (18.98) 10,141 (18.64)
 40–44 127 (11.34) 11,161 (20.95) 11,288 (20.75)
 45–49 217 (19.38) 8,903 (16.71) 9,120 (16.77)
 50–54 233 (20.80) 5,661 (10.63) 5,894 (10.84)
 55–59 238 (21.25) 3,315 (6.22) 3,553 (6.53)
 60–64 161 (14.38) 1,757 (3.30) 1,918 (3.53)
 65–69 55 (4.91) 854 (1.60) 909 (1.67)
 70–74 34 (3.04) 472 (0.89) 506 (0.93)
 75–79 8 (0.71) 159 (0.30) 167 (0.31)
 80–84 ≤5 (≤1.00) 38 (0.07) 40 (0.07)
 85+ 0 (0.00) 8 (0.02) 8 (0.01)
Race/Ethnicity
 Non-Hispanic White 841 (75.09) 38,171 (71.65) 39,012 (71.72)
 Non-Hispanic Black 195 (17.41) 4,418 (8.29) 4,613 (8.48)
 Non-Hispanic American Indian/Alas Native ≤5 (≤1.00) 153 (0.29) 154 (0.28)
 Non-Hispanic Asian/Pacific Islander ≤5 (≤1.00) 922 (1.73) 926 (1.70)
 Hispanic 78 (6.96) 7,900 (14.83) 7,978 (14.67)
 Non-Hispanic, with unknown/unclassifiable race ≤5 (≤1.00) 1,710 (3.21) 1,711 (3.15)
Smoking status at enrollment
 Current 142 (12.68) 8,372 (15.71) 8,514 (15.65)
 Former 383 (34.20) 12,351 (23.18) 12,734 (23.41)
 Never 570 (50.89) 31,279 (58.71) 31,849 (58.55)
 Unknown/missing 25 (2.23) 1272 (2.39) 1,297 (2.38)
Vital status by the end of follow-up (12/31/2015)
 Alive 1,076 (96.07) 51,594 (96.85) 52,670 (96.83)
 Deceased 44 (3.93) 1,680 (3.15) 1,724 (3.17)
First arrival at WTC site
 9/11/2001 515 (45.98) 24,019 (45.09) 24,534 (45.10)
 9/12/2001 189 (16.88) 9,541 (17.91) 9,730 (17.89)
 9/13/2001 to 6/30/2002 349 (31.16) 16,496 (30.96) 16,845 (30.97)
 Not at WTC site 37 (3.30) 2,593 (4.87) 2,630 (4.84)
 Unknown 30 (2.68) 625 (1.17) 655 (1.20)

Legend:

a

Rescue/recovery workers that did not have a prostate cancer diagnosis in the study period

Figure 2 displays adjusted incidence rates for the study. Models were centered at non-Hispanic White participants age 50–54 for both graphs and additionally, never smokers in the secondary models. Figure 2a illustrates an increased adjusted incidence among the WTC Combined Rescue/Recovery cohort coinciding with a decreased incidence among the NYS comparison rates beginning in 2006. From 2009–2015, prostate cancer incidence decreased for both groups. Similarly, Figure 2b illustrates an increased incidence beginning in 2006 for all exposure categories, followed by a gradual decline from 2009–2015. A dose-response trend was observed; however, rates were not significantly different for most calendar years, individually. We estimated change points in 2006 for the primary external analysis (95% CI: 2006–2008) (Figure 3a), as well as the secondary external (95% CI: 2006–2008) (3b) and internal analyses (95% CI: 2006–2007) (3c). The majority of cases had localized (n=867; 77%) tumors, 15.3% were regional (n=171) and 2.5% were distant (n=28). Our sensitivity analysis restricting to only regional and distant tumors yielded no significant change points. However, when evaluating hazard ratios over the entire study period (2002–2015), rates were significantly elevated (3d).

Figure 2: Adjusted Prostate Cancer Incidence Rates.

Figure 2:

a. WTC Combined Rescue Recovery Cohort vs. NYS

Abbreviations: WTC=World Trade Center; NYS=New York State Comparison population; Models are controlled for race/ethnicity and age; rates are centered at non-Hispanic white race/ethnicity and ages 50–54; rates are displayed per 100,000 person-years; blue lines: smoothed adjusting incidence curves for WTC Combined Rescue/Recovery Cohort; red lines: smoothed adjusting incidence curves for NYS comparison population. Line shadows represent 95% confidence intervals.

b. WTC Combined Rescue Recovery Cohort by exposure category

Models are controlled for race/ethnicity and age; rates are centered at non-Hispanic white race/ethnicity and ages 50–54; rates are displayed per 100,000 person-years; red lines: smoothed adjusting incidence curves for point estimates for each year of WTC Combined Rescue/Recovery Cohort who first arrived at the WTC disaster site on 9/11 or were caught in the dust cloud; blue lines: smoothed adjusting incidence curves for WTC Combined Rescue/Recovery Cohort who first arrived at the WTC disaster site on 9/12; green lines: smoothed adjusting incidence curves for WTC Combined Rescue/Recovery Cohort who first arrived at the WTC disaster site on 9/13–6/30/2002. Line shadows represent 95% confidence intervals.

There were 515/24,478 (2.1%), 188/9,692 (1.9%) and 349/16,791 (2.1%) cases among participants in the 9/11 or Dust Cloud, 9/12 and 9/13 or later exposure categories, respectively.

Figure 3: Change Point Models for Incident Prostate Cancer among World Trade Center rescue/recovery workers: March 12, 2002–December 31, 2005.

Figure 3:

Abbreviations: HR: Hazard Ratio; CI, confidence interval; 9/11=9/11/2001

Best-fitting models for 3a, 3b, and 3c all had one change point in 2006. All analyses control for age and race/ethnicity. Figure 3c also controls for ever-smoking. Figures 3a includes the entire Combined World Trade Center (WTC) Rescue/recovery cohort (n=54,394). Figures 3b, 3c and 3d are restricted to those who self-reported an arrival time or dust-cloud exposure at the WTC sites, were at least 30 years old when diagnosed with prostate-cancer and were not non-Hispanic American Indian race/ethnicity (n=50,961).

* Arrived on morning of 9/11 or self-reported dust cloud exposure

Discussion

In the current study, we observed an increased incidence of prostate cancer beginning 5.25 years post-exposure among participants in the WTC Combined Rescue/Recovery Cohort.25 Starting in 2007 and continuing through the end of the study period in 2015, we found a 24% increased risk of prostate cancer relative to NYS rates. In internal analyses, a dose-response trend was observed in both the early (2002–2006) and later (2007–2015) periods of follow-up, with the largest risk estimated in the early period. The increased hazard among those who responded to the disaster earliest or were caught in the dust cloud suggests that a high intensity of exposure may have played some role in premature oncogenesis. Relative to NYS, however, a lower relative risk was observed in the initial period, particularly among those responders who arrived at the WTC disaster site latest.

Earlier assessments among participants followed at the FDNY, GRC and WTCHR have all independently established an elevated risk for prostate cancer.811 Our findings were in support of the previous studies, despite removing duplicate cases between the cohorts that could have artificially inflated risk estimates. This study combined the three cohorts, providing statistical power and identifying the specific period (2007–2015) when the risk appears to be greatest. We found the period from exposure to onset of cancer to be just over 5 years, shorter than prior non-WTC studies1,34 which may reflect the carcinogenicity of exposures experienced at the main WTC disaster site. The finding of an internal positive, monotonic dose-response association during the early (2002–2006) and late (2007–2015) periods is noteworthy. This is especially relevant because certain occupational groups may be at additional risk of prostate cancer, irrespective of WTC exposure. In addition, after controlling for cigarette smoking, an important confounder and one of the few known behavioral risk factors linked to prostate cancer, the association was upheld for those who arrived at the disaster site earliest or were caught in the dust cloud. The results of our sensitivity analysis evaluating WTC-exposure and regional/distant tumors, argue against surveillance bias. We continued to observe a dose-response association despite the absence of a change-point. This observation, in conjunction with our previous report of favorable survival outcomes among WTC Health Program participants, supports further use of this cohort for studying prostate cancer treatments and interventions.

Higher than general population rates of prostate-specific antigen (PSA) screening among WTC-exposed responders may have played a role in the increase in prostate cancer incidence. It is noteworthy that although PSA testing is not a formal part of WTC medical monitoring exam, it is offered to older participants at FDNY exams. Moreover, disaster-related services including diagnostic evaluations for WTC-related cancers and treatment were added to the FDNY responders’ routine screening after 9/11, while other responders may be tested in other primary healthcare settings that offered comparable medical evaluation and treatment. Arguing against surveillance bias are prior studies which have demonstrated similar findings in WTC-exposed cohorts without known formal PSA testing.8,35 The findings of this combined cohort study are consistent with a study from the WTC-exposed GRC, which found: 1) an internal dose-response association using a well-defined exposure metric; 2) high rates of advanced stage tumors which argue against lead-time bias; and 3) an association among young and old participants but no association among participants aged 55–69, a group which is historically screened most frequently.9 However, because we are unable to assess association between exposure and number of PSA monitoring visits, screening cannot be completely discounted for the observed effect.

This current study has several strengths. It is the first to analyze the time from exposure to onset of cancer, in detail, among WTC-exposed responders. In addition to our efforts to reduce the impacts of surveillance bias, another strength of this work is the rigorous efforts to address self-selection bias by removing cancers that occurred within six months of enrollment in a WTC cohort and by requiring enrollment prior to the initiation of cancer coverage in 2012.26 We also believe that this work will be of interest in the broader of context of disaster management, particularly when analyzing time to cancer diagnosis among responders who attended signal events with similar exposures such as the Deepwater Horizon Oil explosion. This study utilized parametric survival modeling with change points to model the hazard ratio (HR) as a nonlinear function of time, similar to those used in non-WTC cancer research24 and in WTC-related respiratory research22,23 In general, the amount of time for prostate cancer to develop in relation to carcinogens known to be present is understudied and thus, this work may begin to fill an important gap in the scientific literature. The use of relative rates rather than standardized incidence ratios avoids reliance on assumptions of proportional incidence across strata that may not be met. This method is also not unduly influenced by small strata.

Finally, a major strength of this study is the continued follow-up of three cohorts of WTC rescue/recovery workers, which has provided a unique opportunity to better understand time from exposure to cancer diagnoses in a human population after a time-delimited exposure to a broad spectrum of environmental carcinogens. The WTC Combined Rescue/Recovery Cohort allows for analytic flexibility by augmenting the statistical power needed for studying cancer in longitudinal survival analyses. Researchers from the cohorts following these workers had previously agreed on a common exposure definition36 and identical case ascertainment using thirteen state cancer registries. The NYS Cancer Registry served as an “honest broker” by consolidating data from the three surveillance groups to ensure data security and confidentiality, harmonizing data formats and de-duplicating data from rescue/recovery workers followed by multiple cohorts so that they were counted once for analyses.25

This study is not without limitations. First, we cannot determine the extent to which other behavioral, occupational and environmental exposures beyond cigarette smoking might have contributed to prostate cancer risk. Other studies of firefighters and police officers with no known exposure to the WTC disaster have also reported increased incidence compared with national rates.3740 Unfortunately, we did not have access to information about years of employment or potentially important occupational exposures. Another limitation is the absence of PSA testing data on the WTC Combined Rescue/Recovery Cohort among those who were tested, although a study on GRC responders failed to find a significant association between frequency of screening exams and prostate cancer incidence.9 Additionally, while we were unable to explore alternate biological pathways for prostate tumorigenesis such as those mediated by stress41, we believe that it is beyond the scope of this study but warrants further exploration in the future. Finally, the WTC Combined Rescue/Recovery Cohort was likely a healthy subset of the general population prior to exposure and resided mostly in the greater New York region, which limits generalizability of these findings to less healthy participants in other regions of the country.

In summary, we observed an increased incidence of prostate cancer beginning 5.25 years post-exposure, substantially shorter than findings from non-WTC studies.1,34 A dose-response trend was observed in both the early (2002–2006) and later (2007–2015) periods of follow-up. Evidence suggests a relationship between WTC exposure and prostate cancer not fully explained by random or systematic error. This research may increase understanding of the period between environmental exposure and cancer incidence in human populations. It increases the understanding of long-term consequences of WTC-exposure, informs surveillance efforts for future environmental disasters and may stimulate further research into environmental risk factors for cancer in this and other cohorts. Our findings support the need for continued research evaluating the burden of prostate cancer in WTC responders.

Table 1b:

Characteristics of prostate cancer cases

Year of diagnosis n (%)
 2002 ≤5 (≤1.0)
 2003 12 (1.1)
 2004 23 (2.1)
 2005 42 (3.8)
 2006 42 (3.8)
 2007 70 (6.3)
 2008 82 (7.3)
 2009 110 (9.8)
 2010 120 (10.7)
 2011 123 (11.0)
 2012 121 (10.8)
 2013 136 (12.1)
 2014 119 (10.6)
 2015 115 (10.3)
Stage
 Localized 867 (77.4)
 Regional 171 (15.3)
 Distant 28 (2.5)
 Unknown 54 (4.8)
Other descriptive statistics Mean (SD)
 Age at diagnosis (years) 60.3 (7.9)
 Age at end of follow-up (years) 65.1 (7.8)
 Length of follow-up (years) 11.2 (2.5)

What this paper adds?

What is already known about this subject?

Prior studies have identified an increased risk of prostate cancer among World Trade Center exposed rescue/recovery workers.

What are the new findings?

Just over five years after the World Trade Center attacks, prostate cancer incidence was elevated among rescue/recovery workers, demonstrating a shorter period from occupational exposure to disease onset when compared with other non-World Trade Center research.

How might this impact on policy or clinical practice in the foreseeable future?

It increases the understanding of long-term consequences of World Trade Center exposures, informs surveillance efforts for future environmental disasters and may stimulate further research into environmental risk factors for cancer in this and other cohorts.

Acknowledgements and disclosures:

We thank the 13 state cancer registries for carrying out record linkages: Bureau of Cancer Epidemiology, New York State Department of Health (DOH); Arizona Cancer Registry Department of Health Services (DOHS); California Cancer Registry, Department of Public Health (DPH); Connecticut Tumor Registry, Connecticut DPH; Florida Cancer Registry, Florida DOH; Massachusetts Cancer Registry, Massachusetts DPH; New Jersey State Cancer Registry, New Jersey DOH and Rutgers Cancer Institute of New Jersey; North Carolina Central Cancer Registry, State Center for Health Statistics; Ohio Cancer Incidence Surveillance System, Ohio DOH; Bureau of Health Statistics and Research, Pennsylvania DOH; Texas Cancer Registry, Texas Department of State Health Services, Virginia Cancer Registry, Virginia DOH, and Washington State Cancer Registry, Washington DOH. Additional Acknowledgements and Disclaimers from individual State Cancer Registries:

Funding: This research was supported through the National Institute for Occupational Safety and Health (NIOSH) cooperative agreements (U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, and U50/OH009739) and contracts (200-2011-39378, 200-2017-93325 and 200-2017-93326). Additionally, this research was supported cooperative agreement 6NU58DP006309 awarded to the New York State Department of Health by the Centers for Disease Control and Prevention (CDC) and by Contract 75N91018D00005 (Task Order 75N91018F00001) from the National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services. This research was also supported by cooperative agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry (ATSDR), CDC, which included support from the National Center for Environmental Health, CDC; and by the New York City Department of Health and Mental Hygiene (NYC DOHMH). This research was also supported by grant P30 CA013330 from the National Cancer Institute (NCI), NIH.

The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California, and contract HHSN261201800009I awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors.

The Connecticut Department of Public Health Human Investigations Committee approved this research project, which used data obtained from the Connecticut Department of Public Health. The Connecticut Department of Public Health does not endorse or assume any responsibility for any analyses, interpretations or conclusions based on the data. The authors assume full responsibility for all such analyses, interpretations and conclusions.

The Florida cancer incidence data used in this report were collected by the Florida Cancer Data System (FCDS), the statewide cancer registry funded by the Florida Department of Health (DOH) and the Centers for Disease Control and Preventions National Program of Cancer Registries (CDC-NPCR). The views expressed herein are solely those of the author(s) and not necessarily reflect those of the DOH or CDC-NPCR.

Cancer incidence data used in these analyses were obtained from the Ohio Cancer Incidence Surveillance System (OCISS), Ohio Department of Health (ODH), a cancer registry partially support by the National Program of Cancer Registries at the Centers for Disease Control and Prevention (CDC) through Cooperative Agreement Number NU58DP006284. Use of these data does not imply that ODH or CDC agrees or disagrees with the analyses, interpretations or conclusions in this report (or publication/presentation).

These data were supplied by the Bureau of Health Statistics & Registries, Pennsylvania Department of Health, Harrisburg, Pennsylvania. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions.

Footnotes

Contributorship statement: The manuscript was conceptualized by: DGG, RZO, DK, CBH and PB.The acquisition, analysis, or interpretation of data for the work was done by: DGG, RZO, DK, JL, RMB, MRF, JEC, CBH and PB. All authors had a role in drafting this work or revising it critically for important intellectual content.

Data Sharing/Data availability: Data that support the findings of the study may be obtained from the corresponding author (CBH) upon reasonable request after approval by the Steering Committee for “Incidence, Latency, and Survival of Cancer Following World Trade Center Exposure” (NIOSH Cooperative Agreement U01 OH011932) in accordance with the study’s official Data Sharing Plan.

Ethics Approval Statements: All responders who were members of any of the three cohorts and either provided informed consent for research or were covered under a research ethics board, or Institutional Review Board (IRB)-approved waiver of consent were eligible for inclusion in analyses. These include: the Albert Einstein College of Medicine/Montefiore Medical Center: IRB#2016–6692; the NYC Department of Health and Mental Hygiene: IRB #16–130; the NYS Department of Health: IRB #16–052; and the Icahn School of Medicine at Mt. Sinai: IRB#: 16–00814.

Competing interests: None declared.

References

  • 1.Haas GP, Delongchamps N, Brawley OW, et al. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol 2008;15(1):3866–71. [published Online First: 2008/02/29] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bostwick DG. Prostatic intraepithelial neoplasia (PIN): Current concepts. 1992;50(S16H):10–19. doi: 10.1002/jcb.240501205 [DOI] [PubMed] [Google Scholar]
  • 3.Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980(32):5–338. [published Online First: 1980/01/01] [PubMed] [Google Scholar]
  • 4.Armenian HK, Lilienfeld AM. The distribution of incubation periods of neoplastic diseases. Am J Epidemiol 1974;99(2):92–100. doi: 10.1093/oxfordjournals.aje.a121599 [published Online First: 1974/02/01] [DOI] [PubMed] [Google Scholar]
  • 5.Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283(22):2975–8. doi: 10.1001/jama.283.22.2975 [published Online First: 2000/06/24] [DOI] [PubMed] [Google Scholar]
  • 6.Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101(6):374–83. doi: 10.1093/jnci/djp001 [published Online First: 2009/03/12] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Auvinen A, Maattanen L, Stenman UH, et al. Lead-time in prostate cancer screening (Finland). Cancer Causes Control 2002;13(3):279–85. doi: 10.1023/a:1015040231402 [published Online First: 2002/05/22] [DOI] [PubMed] [Google Scholar]
  • 8.Shapiro MZ, Wallenstein SR, Dasaro CR, et al. Cancer in General Responders Participating in World Trade Center Health Programs, 2003–2013. JNCI Cancer Spectr 2020;4(1):pkz090. doi: 10.1093/jncics/pkz090 [published Online First: 2020/04/28] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hashim D, Boffetta P, Galsky M, et al. Prostate cancer characteristics in the World Trade Center cohort, 2002–2013. Eur J Cancer Prev 2018;27(4):347–54. doi: 10.1097/CEJ.0000000000000315 [published Online First: 2016/11/30] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Boffetta P, Zeig-Owens R, Wallenstein S, et al. Cancer in World Trade Center responders: Findings from multiple cohorts and options for future study. Am J Ind Med 2016;59(2):96–105. doi: 10.1002/ajim.22555 [published Online First: 2016/01/05] [DOI] [PubMed] [Google Scholar]
  • 11.Zeig-Owens R, Webber MP, Hall CB, et al. Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study. Lancet 2011;378(9794):898–905. doi: 10.1016/S0140-6736(11)60989-6 [published Online First: 2011/09/06] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lioy PJ, Georgopoulos P. The anatomy of the exposures that occurred around the World Trade Center site: 9/11 and beyond. Ann N Y Acad Sci 2006;1076:54–79. doi: 10.1196/annals.1371.002 [published Online First: 2006/11/23] [DOI] [PubMed] [Google Scholar]
  • 13.Lioy PJ, Weisel CP, Millette JR, et al. Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Environ Health Perspect 2002;110(7):703–14. doi: 10.1289/ehp.02110703 [published Online First: 2002/07/16] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Claudio L. Environmental aftermath. Environ Health Perspect 2001;109(11):A528–36. doi: 10.1289/ehp.109-a528 [published Online First: 2001/11/20] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sun XL, Kido T, Honma S, et al. The relationship between dioxins exposure and risk of prostate cancer with steroid hormone and age in Vietnamese men. Sci Total Environ 2017;595:842–48. doi: 10.1016/j.scitotenv.2017.04.013 [published Online First: 2017/04/17] [DOI] [PubMed] [Google Scholar]
  • 16.Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Ninth Biennial Update); Board on the Health of Select Populations; Institute of Medicine. Veterans and Agent Orange: Update 2012 Washington (DC): National Academies Press (US);Cancer; 2014 [PubMed] [Google Scholar]
  • 17.Prins GS. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 2008;15(3):649–56. doi: 10.1677/ERC-08-0043 [published Online First: 2008/06/06] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gong Y, Wang L, Yu H, et al. Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade. Mol Cancer Res 2019;17(8):1605–12. doi: 10.1158/1541-7786.MCR-19-0115 [published Online First: 2019/06/22] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Webber MP, Glaser MS, Weakley J, et al. Physician-diagnosed respiratory conditions and mental health symptoms 7–9 years following the World Trade Center disaster. Am J Ind Med 2011;54(9):661–71. doi: 10.1002/ajim.20993 [published Online First: 2011/10/04] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Herbert R, Moline J, Skloot G, et al. The World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening program. Environ Health Perspect 2006;114(12):1853–8. doi: 10.1289/ehp.9592 [published Online First: 2006/12/23] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Farfel M, DiGrande L, Brackbill R, et al. An overview of 9/11 experiences and respiratory and mental health conditions among World Trade Center Health Registry enrollees. J Urban Health 2008;85(6):880–909. doi: 10.1007/s11524-008-9317-4 [published Online First: 2008/09/12] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Liu X, Yip J, Zeig-Owens R, et al. The Effect of World Trade Center Exposure on the Timing of Diagnoses of Obstructive Airway Disease, Chronic Rhinosinusitis, and Gastroesophageal Reflux Disease. Front Public Health 2017;5:2. doi: 10.3389/fpubh.2017.00002 [published Online First: 2017/02/24] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Glaser MS, Webber MP, Zeig-Owens R, et al. Estimating the time interval between exposure to the World Trade Center disaster and incident diagnoses of obstructive airway disease. Am J Epidemiol 2014;180(3):272–9. doi: 10.1093/aje/kwu137 [published Online First: 2014/07/02] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Goodman MS, Li Y, Tiwari RC. Detecting multiple change points in piecewise constant hazard functions. J Appl Stat 2011;38(11):2523–32. doi: 10.1080/02664763.2011.559209 [published Online First: 2011/01/01] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brackbill R, Kahn A, Li J, et al. Combining Three Cohorts of WTC Rescue/Recovery Workers for Assessing Cancer Incidence and Mortality. Preprints 1020944/preprints2021010105v1) 2021 [Google Scholar]
  • 26.Centers for Disease Control and Prevention. Covered Conditions - World Trade Center Health Program 2020 [Available from: https://www.cdc.gov/wtc/conditions.html accessed May 27, 2020.
  • 27.Office NYCIB. When New Yorkers Move Out of New York City Where Do They Go?, 2014. [Google Scholar]
  • 28.NTP 12th Report on Carcinogens. Report on carcinogens : carcinogen profiles 2011;12:iii–499. [published Online First: 2011/08/09] [PubMed] [Google Scholar]
  • 29.International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Painting, firefighting, and shiftwork. Lyon, France: IARC 2010. [PMC free article] [PubMed] [Google Scholar]
  • 30.Jensen U, Lutkebohmert C. A Cox-type regression model with change-points in the covariates. Lifetime Data Anal 2008;14(3):267–85. doi: 10.1007/s10985-008-9083-3 [published Online First: 2008/01/29] [DOI] [PubMed] [Google Scholar]
  • 31.Hall CB, Lipton RB, Sliwinski M, et al. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer’s disease. Statistics in medicine 2000;19(11–12):1555–66. [published Online First: 2000/06/09] [DOI] [PubMed] [Google Scholar]
  • 32.Hall CB, Ying J, Kuo L, et al. Bayesian and profile likelihood change point methods for modeling cognitive function over time. Computational Statistics & Data Analysis 2003;42(1–2):91–109. [Google Scholar]
  • 33.Young JL Jr, Roffers SD, Ries LAG, et al. SEER Summary Staging Manual - 2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01–4969, Bethesda, MD., 2001. [Google Scholar]
  • 34.Watanabe KK, Kang HK. Mortality patterns among Vietnam veterans: a 24-year retrospective analysis. J Occup Environ Med 1996;38(3):272–8. doi: 10.1097/00043764-199603000-00012 [published Online First: 1996/03/01] [DOI] [PubMed] [Google Scholar]
  • 35.Li J, Brackbill RM, Liao TS, et al. Ten-year cancer incidence in rescue/recovery workers and civilians exposed to the September 11, 2001 terrorist attacks on the World Trade Center. Am J Ind Med 2016;59(9):709–21. doi: 10.1002/ajim.22638 [published Online First: 2016/09/02] [DOI] [PubMed] [Google Scholar]
  • 36.Weakley J, Maslow C, WTC Working Group. Defining common categories of exposure among four cohorts of rescue/recovery workers who responded to the World Trade Center disaster. Council of State and Territorial Epidemiologists (CSTE) Annual Conference. Pittsburgh, PA: 2011. [Google Scholar]
  • 37.Lee DJ, Koru-Sengul T, Hernandez MN, et al. Cancer risk among career male and female Florida firefighters: Evidence from the Florida Firefighter Cancer Registry (1981–2014). Am J Ind Med 2020;63(4):285–99. doi: 10.1002/ajim.23086 [published Online First: 2020/01/14] [DOI] [PubMed] [Google Scholar]
  • 38.Sritharan J, MacLeod J, Harris S, et al. Prostate cancer surveillance by occupation and industry: the Canadian Census Health and Environment Cohort (CanCHEC). Cancer Med 2018;7(4):1468–78. doi: 10.1002/cam4.1358 [published Online First: 2018/03/02] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Daniels RD, Kubale TL, Yiin JH, et al. Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950–2009). Occup Environ Med 2014;71(6):388–97. doi: 10.1136/oemed-2013-101662 [published Online First: 2013/10/22] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Demers PA, Checkoway H, Vaughan TL, et al. Cancer incidence among firefighters in Seattle and Tacoma, Washington (United States). Cancer Causes Control 1994;5(2):129–35. doi: 10.1007/BF01830258 [published Online First: 1994/03/01] [DOI] [PubMed] [Google Scholar]
  • 41.Clouston SAP, Kuan P, Kotov R, et al. Risk factors for incident prostate cancer in a cohort of world trade center responders. BMC Psychiatry 2019;19(1):389. doi: 10.1186/s12888-019-2383-1 [published Online First: 2019/12/12] [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES